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Abstract
Antibiotics are frequently administered orally to treat bacterial infections not necessarily
related to the gastrointestinal system. This has adverse effects on the commensal gut
microbial community, as it disrupts the intricate balance between specific bacterial groups
within this ecosystem, potentially leading to dysbiosis. We hypothesized that modulation of
community composition and function induced by antibiotics affects intestinal integrity
depending on the antibiotic administered. To address this a total of 60 Wistar rats (housed
in pairs with 6 cages per group) were dosed by oral gavage with either amoxicillin (AMX),
cefotaxime (CTX), vancomycin (VAN), metronidazole (MTZ), or water (CON) daily for 10–
11 days. Bacterial composition, alpha diversity and caecum short chain fatty acid levels
were significantly affected by AMX, CTX and VAN, and varied among antibiotic treatments.
A general decrease in diversity and an increase in the relative abundance of Proteobacteria
was observed for all three antibiotics. Additionally, the relative abundance of Bifidobacteria-
ceae was increased in the CTX group and both Lactobacillaceae and Verrucomicrobiaceae
were increased in the VAN group compared to the CON group. No changes in microbiota
composition or function were observed following MTZ treatment. Intestinal permeability to 4
kDa FITC-dextran decreased after CTX and VAN treatment and increased following MTZ
treatment. Plasma haptoglobin levels were increased by both AMX and CTX but no
changes in expression of host tight junction genes were found in any treatment group. A
strong correlation between the level of caecal succinate, the relative abundance of Clostri-
diaceae 1 family in the caecum, and the level of acute phase protein haptoglobin in blood
plasma was observed. In conclusion, antibiotic-induced changes in microbiota may be
linked to alterations in intestinal permeability, although the specific interactions remain to be
elucidated as changes in permeability did not always result from major changes in micro-
biota and vice versa.
PLOS ONE | DOI:10.1371/journal.pone.0144854 December 21, 2015 1 / 17
a11111
OPEN ACCESS
Citation: Tulstrup MV-L, Christensen EG, Carvalho
V, Linninge C, Ahrné S, Højberg O, et al. (2015)
Antibiotic Treatment Affects Intestinal Permeability
and Gut Microbial Composition in Wistar Rats
Dependent on Antibiotic Class. PLoS ONE 10(12):
e0144854. doi:10.1371/journal.pone.0144854
Editor: Gunnar Loh, Max Rubner-Institut, GERMANY
Received: September 1, 2015
Accepted: November 24, 2015
Published: December 21, 2015
Copyright: © 2015 Tulstrup et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All sequencing data
are deposited at the NCBI Sequence Read Archive
(accession No. SRP065667)
Funding: The present work was funded by a grant
from the Danish Council for Independent Research,
Technology and Production Sciences (DFF-1335-
00092) and The Royal Physiographic Society of
Lund.
Competing Interests: The authors have declared
that no competing interests exist.
Introduction
The gut microbiota is considered to have great impact on host health through either direct
interaction with host cells or through production of metabolites such as short chain fatty acids
[1]. Any modulation of the gut microbiota may therefore potentially lead to adverse or benefi-
cial host effects, which may be associated to changes in intestinal integrity [2]. Many bacterial
infections in humans are treated with orally administered antibiotics irrespective of the actual
location of the infection. Such treatment will inevitably affect the complex and finely tuned
microbial ecosystem residing in the gut [3]. Numerous studies have examined the effects of dif-
ferent antibiotics classes on the gut microbiota [4–11], however few have focused on the pri-
mary or secondary effects on intestinal integrity [12–14]. Intestinal permeability is a frequently
employed marker for intestinal health, as increased intestinal permeability may lead to inflam-
mation caused by bacterial components, such as lipopolysaccharide (LPS), crossing the epithe-
lial barrier. In one study metronidazole was shown to increase the inflammatory tone of the
intestine, which was linked to a disruption of the microbiota [12]. In another study high-fat
diet increased intestinal permeability, but subsequent antibiotic treatment was shown to reduce
the intestinal permeability again [13]. Others have shown that antibiotic treatment in child-
hood is associated with Crohn’s disease [15], which is connected to increased intestinal perme-
ability [16]. Intestinal permeability in the gut is mainly controlled by the interaction between
tight junction proteins linking epithelial cells. Small molecules, such as ions, are considered to
pass through a high conducting ‘pore’ pathway in the tight junctions, while larger molecules,
including LPS, may pass through the ‘leak’ pathway as previously defined [2,17]. Intestinal per-
meability, by the ‘leak’ pathway, can be assessed by determining the permeability of FITC-dex-
tran with a defined molecular size [2,13,17].
The effect of antibiotics on the bacterial composition and consequently the intestinal perme-
ability is expected to be dependent on the specific targets species of the antibiotics and there-
fore different classes of antibiotics may have different effects on intestinal health. To address
this we examined effects of four antibiotics, namely; amoxicillin (AMX), cefotaxime (CTX),
vancomycin (VAN), and metronidazole (MTZ) on the gut microbial composition and intesti-
nal integrity in female Wistar rats. These antibiotics represent different classes and were chosen
due to their common use for treating humans infections and varying bacterial targets (Table 1).
Changes in bacterial composition were determined using high-throughput sequencing of the
V3-region of the 16S rRNA encoding gene, while changes in intestinal permeability were deter-
mined in vivo by FITC-dextran gut permeability assay, acute phase protein haptoglobin levels
in blood plasma and by measuring intestinal gene expression.
Materials and Methods
Ethics Statement
Animal experiments were carried out at the DTU National Food Institute (Mørkhøj, Denmark)
facilities. Ethical approval was given by the Danish Animal Experiments Inspectorate. The
Table 1. Characteristics of antibiotics used in the study.
Antibiotic Abbr. Class Bacterial targets [3]
Amoxicillin AMX Penicillin Moderate spectrum, Gram-positives
Cefotaxime CTX Cephalosporin (3rd gen.) Broad-spectrum, Gram-positives and -negatives
Vancomycin VAN Glycopeptide Gram-positives
Metronidazole MTZ Nitroimidazole Broad-spectrum, anaerobes.
doi:10.1371/journal.pone.0144854.t001
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authorization number given is 2012-15-2934-00089 C2. The experiments were overseen by the
National Food Institutes in-house Animal Welfare Committee for animal care and use.
Animals and housing
8-week old specific pathogen free female Wistar Hannover rats (n = 60) were purchased from
Taconic (Lille Skensved, Denmark) and housed under controlled environmental conditions
(12-hours light/dark cycles, temperature 21.5 ± 0.3°C, relative humidity 51.3 ± 3.1%, 8–10 air
changes per hour). Animals had access to ad libitum water and feed (Altromin 1324, Altromin
Spezialfutter GmbH, Germany) throughout the experiment. Animal weight, as well as feed and
water intake was monitored weekly during the intervention period.
Experimental design
Upon arrival animals were caged in pairs. The following day animals were weighed and the
cages were evenly allocated into five treatment groups (six cages in each group) based on
weight, and acclimatized for 2 weeks before the experimental period was initiated. Co-housing
of animals was done to adhere to local animal welfare recommendations and allowed different
analyses to be performed on each individual, whilst noting their non-independency. During
the experimental period animals received a daily dosage of 0.5 mL of antibiotic solution
(Table 1) AMX; 60 mg/mL amoxicillin (Sigma-Aldrich, A8523), CTX; 8 mg/mL cefotaxime
(Sigma-Aldrich, C7912), VAN; 8 mg/mL vancomycin (Sigma-Aldrich, 861987), MTZ; 8 mg/
mL Metronidazole (Sigma-Aldrich, M1547) or water (CON) by oral gavage for 10 or 11 days.
Faecal pellets were collected directly from the individual rats during the trial and immediately
frozen at -20°C until analysis.
Dissection of animals
The animals that had not received FITC-dextran were dissected (n = 30). The caecum was
removed, weighed, the pH of content measured (Thermo Scientific, Orion 3 Star) and samples
of caecal content as well as ileum and colon content were collected and stored at -20°C. A sam-
ple of caecal content was also snap-frozen in liquid nitrogen and stores at -80°C for later short
chain fatty acid analysis. Approximately 0.5–1 cm tissue samples from the colon were stored in
RNAlater1 (Life Technologies) at -80°C for gene expression analysis.
Extraction of bacterial community DNA
Community DNA was extracted from faecal samples collected on the initial day of dosing (Day
0), and the day before the euthanization of the first animals (Day 9), as well as from ileal and
caecal content using the MoBio PowerLyzer1 Power Soil1 DNA Isolation Kit (MoBio Labora-
tories, Carlsbad, CA) according to the manufacturer’s recommendations with minor modifica-
tions: A maximum of 200 mg samples was used for extraction and samples were heated to
65°C for 10 min after addition of the C1 solution. Bead beating was conducted at 30 cycles/s
for 4 min (Retsch MM 300 mixer mill). DNA concentrations were measured with the Qubit
dsDNA HS kit (Life Technologies).
Bacterial load
Faecal samples collected from one animal in each cage (n = 30) on Day 8 (stored at -20°C)
were used for plate culturing. Ten-fold dilution series of the faecal samples were prepared in
peptone saline diluent and plated onWilkins-Chalgren agar (WCA, Oxoid). Plates were incu-
bated at 37°C for 3 days under anaerobic conditions before enumeration. Extracted community
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DNA from faecal samples collected from the same animals (n = 30) on Day 9 (stored at -20°C)
was used for qPCR based assessment of bacteria load based on the concentration of the 16S
rRNA gene. The V3-region of the 16S rRNA gene was amplified in triplicate for each sample,
using universal primers HDA1 and HDA2 (Walter et al, 2000). PCR reactions contained 5.5 μL
LightCycler1 480 II SYBR Green I Master (Roche Applied Science), 0.2 μM of each primer and
0.2 μL template DNA in a total reaction volume of 11 μL. Reactions conditions were: Initial
95°C for 5 minutes followed by 45 cycles of 95°C for 10 seconds, 60°C for 15 seconds and 72°C
for 45 seconds. This was followed by melting curve generation (95°C for 5 seconds, 68°C for 1
minutes and increasing the temperature to 98°C with a rate of 0.11°C /second with continuous
fluorescence detection). The qPCR was run in 384-well format on a LightCycler1 480 II
(Roche Applied Science) and analysed using the LightCycler1 480 software. Tenfold dilutions
of a linearized (SphI-digested) plasmid standard, construction by cloning the 199bp V3 PCR
amplification product of E. coli (ATCC 25922) into the pCR14Blunt-TOPO vector (Invitro-
gen), was used for quantification of 16S rRNA genes. Additionally, the quantity of 16S rRNA
genes relative to the single-copy rat host gene, TNF-α, was assessed using primers TNF_F 5’-
CTGAGAGCCCCCAATCTGTG -3’ and TNF_R 5’-TCCAGTGAGTTCCGAAAGCC -3’) and
the same template and reaction conditions [18].
Amplicon sequencing of the 16S rRNA encoding gene
The bacterial composition was determined by sequencing the V3-region of the 16S rRNA gene
in the extracted bacterial community DNA. Amplification of the V3-region and subsequent
sequencing was performed using the Ion Torrent PGM platform (Life Technologies) as previ-
ously published [19]. Briefly, the V3-region of the 16S rRNA gene was amplified using a univer-
sal forward primer (PBU 5’-A-adapter-TCAG-barcode-CCTACGGGAGGCAGCAG-3’)
with a unique 10–12 bp barcode for each bacterial community (IonXpress barcode as suggested
by the supplier, Life Technologies) and a universal reverse primer (PBR 5’-trP1-adapter-
ATTACCGCGGCTGCTGG-3’). The PCR reactions were conducted with 4 μL HF-buffer, 0.4μL
dNTP (10mM of each base), 1 μM forward primer, 1 μM reverse primer, 5 ng template DNA,
and 0.2 μL Phusion High-Fidelity DNA polymerase (Thermo Scientific) in a total reaction vol-
ume of 20 μL. Reaction conditions were as follows: Initial 98°C for 30 seconds followed by 24
cycles of 98°C for 15 seconds and 72°C for 30 seconds and finally 72°C for 5 minutes before cool-
ing to 4°C. Products were purified by electrophoresis in 1.5% agarose gels with SYBR-safe at 3.5
V/cm for 90 min, visualized with the Safe Imager™ 2.0 (Invitogen) and bands with expected size
of approximately 260 bp were excised from the gel. DNA was extracted using MiniElute1 Gel
extraction kit (Qiagen) following the recommendations of the manufacturer and DNA concen-
trations were determined with Qubit HS assay. Finally a library was constructed by mixing an
equal amount of PCR products from each original community. Sequencing was performed on a
318-chip for Ion Torrent sequencing using the Ion OneTouch™ 200 Template Kit v2 DL.
Sequence data were obtained in FASTQ format and further processed using CLC bio genomic
workbench (Qiagen) in order to de-multiplex and remove sequencing primers. Further quality
trimming using default settings (remove low quality nucleotides pbase-calling error = 0.05, trim
ambiguous nucleotides = 2) and filtering only reads with a final length between 110bp– 180bp
was performed before exporting reads in FASTA format. The number of good quality reads used
for taxonomical assignment ranged from 17,205 to 96,897 (except for one faecal sample, from
before the intervention, that was represented by only 2,555 reads). All sequence reads were taxo-
nomically classified using the Ribosomal Database Project Multi-classifier tool [20]. A bootstrap
cut-off 50%, was chosen as recommended for fragments below 250bp and previously shown
to be effective [21]. Relative abundance of bacterial taxa (at phylum and family level) were
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determined for each community by comparing the number of reads assigned to a specific taxa to
total number of reads assigned to the bacterial root. For fold-change calculations and log trans-
formation a relative abundance of 0.0005% analogous to 1 read in 200.000 reads was applied as a
detection level. Principle component analysis (PCA) was performed on log transformed count
data at the family level using the LatentiX 2.12 (Latent5; http://www.latentix.com) software
package as previously described [22]. Sequencing data is deposited at NCBI Sequence Read
Archive with the accession number SRP065667.
In vivo intestinal permeability assay
Intestinal permeability was determined on the day of euthanization by measuring the perme-
ability of FITC-dextran in fasted animals by an approach similar to previously reported
[13,19]. One animal in each cage was dosed with 0.5 mL 120 mg/mL FITC-dextran (4kDa,
Sigma-Aldrich, FD-4) per 100 g body weight (corresponding to 600 mg/kg animal), while the
other animal was dosed with a corresponding dose of phosphate buffered saline (PBS). Exactly
two hours after dosing animals were euthanized (CO2 and decapitation), and blood was col-
lected from the neck into 50 ml Falcon tubes containing 100 μL EDTA (0.5M, pH 8, Ambion).
Blood was centrifuged (1500 G, 10 min, 4°C), and plasma collected. Plasma was centrifuged
again (5 min) before mixing 1:1 with PBS. Plasma-PBS solutions were stored dark at 5°C, until
analysis the same day. Fluorescence was measured in three replicate wells for each sample
(75 μL) in black 96-well microtiter plates (Proxiplate-96 F, Perkin Elmer) using a Victor TM
X4 Plate reader (Perkin Elmer) with excitation at 485 nm and emission at 535 nm. Concentra-
tions were calculated from a standard curve.
Haptoglobin measurements
Haptoglobin was measured in blood plasma obtained from the animals, that had not received
FITC-dextran (n = 30), with the "PHASE" TMHaptoglobin Assay (Tridelta Development Ltd,
Kildare, Ireland,) according to the manufacturer’s recommendations. The samples were mea-
sured in duplicates and concentrations calculated from a standard curve.
RNA extraction, cDNA preparation and Gene expression analysis
Total RNA was extracted from approximately 20 mg of colon tissue using the RNeasy Plus
Mini Kit (Qiagen) and cDNA prepared from 500 ng RNA in 20 μl reactions using the Super-
Script VILO cDNA Synthesis Kit (Life technologies) as previously described [19]. The relative
gene expression of the tight junction proteins claudin-1, ZO-1, and occludin, as well as Mucin
2 (Muc2), involved in mucin production, were determined with quantitative PCR using actin
beta (Actb) and glyceraldehyde 3-phosphate dehydrogenase (Gapdh) as reference genes.
Short chain fatty acid (SCFA) analysis
Caecum content samples (approx. 200–500 mg) were thawed and transferred to 10 mL centri-
fuge tubes containing 3–4 glass beads (diam. 3 mm). The tubes were weighed, and a volume of
3–5 mL 0.028 M NaOH was added; the exact dilution factor was calculated for each sample.
The tubes were shaken and vortexed intensively for 2 min. One milliliter suspension was trans-
ferred to a 10 mL centrifuge tube together with 100 μL internal standard (2-ethylbutyric acid,
Sigma-Aldrich Denmark A/S, Vallensbæk Strand, Denmark) to a final concentration of 10
mM. Hereafter the samples were treated as previously described [23]. One milliliter of the
diluted sample was extracted by adding 0.5 mL of concentrated HCl and 2 mL of diethyl ether
and vortex-mixing for 30 s. After centrifugation (3,000 × g for 10 min), 50 μL of the ether layer
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was transferred to a 100 μL vial and 10 μL of the derivatization reagent N-methyl–N-t-butyldi-
methylsilyltrifluoroacetamide (Sigma-Aldrich Denmark A/S) was added. The reaction mixture
was vortex-mixed and incubated at 80°C for 20 min, followed by a further incubation at room
temperature for 48 h. The standard mixture of SCFA’s was the same as previously described
[24]. Quantification of SCFA, lactic acid and succinic acid, was performed on a Hewlett Pack-
ard gas chromatograph (Model 6890, Hewlett Packard, Agilent Technologies, Naerum, Den-
mark) equipped with a flame-ionization detector and a 30-m ZB-5 column with an internal
diameter of 0.32 mm and coated with 5%-phenyl 95%- dimethylpolysiloxane with a film thick-
ness of 0.25 μm. The samples were injected with an auto injector (Model G 1513A, Hewlett-
Packard), and the chromatograms were integrated using HP GC ChemStation software (Agi-
lent Technologies). Detector and injector temperatures were set to 250°C. The carrier gas was
helium, with a pressure of 62.6 kPa. A sample volume of 2 μL was injected with a split ratio of
20. The compounds were eluted with a temperature gradient of the following shape: held at
70°C for 3 min, increased to 110°C at 10°C / min, further increased to 290°C at 20°C / min, and
held for 5 min.
Data handling and statistics
Statistical analysis was conducted in GraphPad Prism (version 5.03; GraphPad Software Inc.,
La Jolla, CA) unless stated otherwise. Differences between treatment groups and the control
group were assessed by the unpaired t-test or the non-parametric Mann-Whitney test as appro-
priate. Statistical analysis of 16S rRNA gene sequencing data was done with the web server
implementation of the Metastats tool for detection of differentially abundant features (http://
metastats.cbcb.umd.edu/detection.html) based on 1000 permutations and a q-value signifi-
cance level of 0.05 [25]. For calculation of Shannon diversity index, sequence reads were
assigned to operational taxonomic units (OTUs), using UCLUST [26] at 97% similarity thresh-
old in QIIME v1.8 [27]. The Shannon Diversity index was calculated based on the output OTU
table.
Results
Changes in body measurements during treatment
Animal body-weight gain did not differ between the CON group and any of the four treatment
groups during the experiment (Fig 1A). Animals in the AMX group had a lower average feed
intake per day during the intervention period compared to CON (P = 0.006), while animals in
the MTZ group had a higher feed intake (P = 0.01) (Fig 1B). Animals in the AMX, CTX, and
MTZ groups had a higher average water intake per day, than animals in the CON group
(P = 0.001, P = 0.002, P = 0.02, respectively) (Fig 1C). Administration of AMX and VAN both
resulted in increased caecum weight compared to CON (P = 0.04 and P = 0.002) (Fig 1D).
Additionally the pH was higher in caecum content of the VAN group compared to the CON
group (P = 0.0009) (Fig 1E).
Changes in bacterial load following antibiotic treatment
The total bacterial load was determined by culture dependent as well as culture independent
methods. Anaerobic culturing of faecal samples revealed significantly higher bacterial load in
animals treated with AMX and VAN compared to CON, (P< 0.0001 and P = 0.005) (Fig 1F).
Administration of AMX also led to higher total number of 16S copies per gram faecal content
(P = 0.06) compared to CON (Fig 1G) determined by qPCR. The ratio of bacterial DNA to
eukaryotic DNA, represented by copies of the 16S rRNA gene and the TNF-α host gene
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Fig 1. Effects of antibiotics on anthropometric measures and bacterial load. (A) Weight gain during the intervention with antibiotics (Day 0 to 9). (B)
Average feed intake per day during the intervention period. (C) Average water intake per day during the intervention period. (D) Weight of caecum and (E) pH
in caecum content. (F) Total anaerobic bacterial load in faecal samples determined by culturing onWilkins-Chalgren agar. (G) Total number of 16S rRNA
gene copies/g faecal sample determined by qPCR and (H) 16S rRNA gene to TNF gene ratio in faecal samples determined by qPCR. In all panels boxplots
with whisker denoting the full range are shown. Significant differences between treatment groups and the control group are indicated by asterisks (*P < 0.05,
**P < 0.01, ***P < 0.001). CON, control; AMX, amoxicillin; CTX, cefotaxime; VAN, vancomycin; MTZ, Metronidazole.
doi:10.1371/journal.pone.0144854.g001
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respectively, was significantly higher for AMX, CTX, and VAN compared to CON (Fig 1H,
P = 0.0007, P = 0.01, and P = 0.01, respectively).
Changes in bacterial composition following antibiotic treatment
The bacterial composition in the AMX, CTX, and VAN groups differed significantly from the
CON group in all three compartments, namely ileum content, caecum content and faecal sam-
ples at the endpoint, while MTZ did not affect the bacterial composition (Figs 2 and 3). The
calculated Shannon diversity index showed a significantly lower alpha diversity for AMX, CTX
and VAN in both faecal samples (Day 9) and caecum content, while no differences were found
in the MTZ group (Fig 2B). Principal component analysis (PCA) showed that AMX and VAN
treatment resulted in clustering of samples from all three compartments (ileum, caecum and
faeces), while only faecal and caecal samples clustered together in the CTX, MTZ and CON
groups (Fig 4). Each of the antibiotic treatment groups clustered differently from the others
when including only caecal and faecal samples in the PCA (S1 Fig). No difference was observed
between MTZ and CON, however PCA modeling based on these two groups alone did show a
slight difference for caecal samples (data not shown). The loading plot (Fig 4B) indicated that
Proteobacteria and specifically Enterobacteriaceaemay be driving the shift towards a higher
PC#2 score for antibiotics AMX, VAN and CTX. Generally the ileum samples showed a lot of
variation within groups, however it was observed that both AMX and VAN treatment reduced
beta diversity (S2 Fig). The average bacterial community compositions in faecal samples taken
before treatment (faeces Day 0) were similar for all groups (Fig 2).
Overall, the bacterial composition in samples from all three compartments (ileal, caecal and
faecal samples) within the same treatment group changed in the same direction as compared to
CON (Fig 3). The relative abundance of families within the Firmicutes and Actinobacteria
phyla were generally reduced following treatment with AMX in all three compartments, while
families within the Proteobacteria were increased (Figs 2A and 3). Within the Bacteroidetes, an
increase in the relative abundance of Bacteroidaceae and a decrease in both Rikenellaceae and
Porphyromonadaceae following AMX treatment was noted. The response of the bacterial com-
munity to VAN was similar to AMX, however the Verrucomicrobiaceae were significantly
increased (in all three compartments) only after VAN treatment. Treatment with CTX resulted
in more subtle changes of the community structure than observed for AMX and VAN (Fig 3),
including significant increases of relative abundances of Bacteroidaceae, Rikenellaceae and
Enterococcaceae and reductions in relative abundances of Porphyromonadaceae, Ruminococca-
ceae and Peptococcaceae 1. Nevertheless, CTX was the only antibiotic causing a significant
increase in Bifidobacteriaceae (Fig 3).
Intestinal permeability
Antibiotic treatment with CTX or VAN resulted in lower FITC-dextran plasma concentrations
compared to CON (P = 0.04, and P = 0.04, respectively) following oral administration, indicat-
ing decreased intestinal permeability (Fig 5A). Oppositely, administration of MTZ increased
the plasma FITC-dextran concentration (P = 0.02) compared to CON (Fig 5A). The acute
phase protein haptoglobin level was increased in the AMX group (P = 0.03) and a trend of
increase was seen in the CTX group (P = 0.06) compared to the control group (Fig 5B). These
differences were driven by two out of six animals in the AMX as well as in the CTX group,
which had levels of haptoglobin that were approximately four times higher than the mean
value of the CON group.
No significant difference in the relative expression of ZO-1, occludin, Claudin-1 orMuc2
were found between the CON group and any of the antibiotic treatment groups (S2 Fig)
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Fig 2. Bacterial community composition and Shannon diversity in faeces, caecum and ileum content based on 16S rRNA gene sequencing. (A)
The average bacterial composition for each treatment group is shown at the phylum level for faecal samples (Day 0 and Day 9), caecal and ileal content. (B)
Shannon diversity index determined in faecal samples (Day 0 and 9), caecal and ileal content for animal in CON, control (grey); AMX, amoxicillin (blue); CTX,
cefotaxime (green); VAN, vancomycin (yellow) and MTZ, Metronidazole (red) groups. Boxplots with whisker denoting the full range are shown. Significant
differences from CON group are indicated by asterisks (*P < 0.05, **P < 0.01).
doi:10.1371/journal.pone.0144854.g002
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Changes in short chain fatty acids and succinate in caecum
Treatment with the different classes of antibiotics resulted in changes in caecum levels of SCFA
and succinate compared to the CON group (Fig 6). Acetate and propionate levels were both
lower in the VAN group (P = 0.02 and P = 0.03), butyrate was lower in the AMX and VAN
groups (both P = 0.01), valerate was lower in the AMX, CTX and VAN groups (P = 0.006,
P = 0.009 and P = 0.01) and succinate was higher in the AMX, CTX and VAN groups
(P = 0.01, P = 0.03 and P = 0.04) compared to the CON group. No statistically significant dif-
ferences in SCFA’s and succinate levels were observed for the MTZ group.
Discussion
As expected, administration of AMX, CTX and VAN for ten days resulted in major shifts in
the microbial communities and reduction of Shannon diversity in caecal and faecal samples
(Figs 2, 3 and 4). The shifts in community structure were distinct for the different classes of
antibiotics with close clustering of samples within treatment group (S1 Fig). No effects on the
microbiota were seen following treatment with MTZ, which is probably because only low con-
centrations of active metronidazole reach the ileum, caecum and colon, as this antibiotic is well
absorbed in the small intestine [28]. Although antibiotic treatment is generally anticipated to
reduce bacterial loads, cultivation-based and molecular methods both revealed an increase in
Fig 3. Fold change of bacterial families for treatment groups compared to the control group in ileum, caecum and faeces. Values show fold-changes
(log2) in relative abundance (rel. abun.) of bacterial families in ileum (I), caecum (C) and faeces (F) of antibiotic treated groups (ABX) compared to the same
bacterial groups in the control (CON) group (log2(rel. abun. ABX / rel. abun. CON)). Only bacterial families which change significantly are shown. Intensity of
green and red shading indicate levels of increase or decrease respectively and asterisks indicate significant differences after correcting for multiple testing
(q<0.05). When no reads were observed for a specific family, a value of 0.0005%was applied as a lower detection limit for calculations (fold-changes
indicated with or).
doi:10.1371/journal.pone.0144854.g003
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the total bacterial loads after treatment with AMX or VAN (Fig 1F–1H). This was presumably
caused by expansion of intrinsically resistant bacterial groups to occupy new niches within the
gut environment, and has previously been noted in other studies [9].
Treatment with AMX, CTX and VAN resulted in changes in SCFA levels as well as
increased levels of succinate in the caecum, which was undetectable in the CON group (Fig 6).
Increased succinate could be attributed to the increase in relative abundance of Bacteroidaceae
that includes species known for succinate production [29]. A streptomycin-induced increase in
succinate levels has recently been shown to facilitate expansion of the human pathogen Clos-
tridium difficile (Peptostreptococcaceae family) in the mouse gut [30]. In the present study we
did not observe this effect at the family level, but on the contrary found a decrease in the rela-
tive abundance of Peptostreptococcaceae in the ileum and caecum of animals treated with AMX
and VAN, respectively (Fig 3). We did however find a strong correlation (r = 0.73, p< 0.0001)
between the caecum succinate concentration and the relative abundance of the Clostridiaceae 1
family (Fig 7A). This family of Clostridiales contains the genus Clostridium sensu stricto with
Fig 4. Principal component analysis (PCA) of the relative abundances of detected bacterial families in caecal, faecal and ileal samples. (A) Score
plot showing samples grouped according to treatment groups CON (black), AMX (blue), CTX (green), VAN (yellow) and MTZ (red), with six animals in each
group.  Caecal samples; + Faeces samples and Δ Ilium samples. (B) Loading plot indicating each of the bacterial families colored according to phylum.
Firm, Firmicutes (blue); Bact, Bacteroidetes (red); Prot, Proteobacteria (green), Acti, Actinobacteria (yellow); Tene, Tenericutes (light blue); Defe,
Deferribacteres (purple); Verr, Verrucomicrobia (lilac) and Cyan, Cyanobacteria (grey).
doi:10.1371/journal.pone.0144854.g004
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Fig 5. Blood plasmameasurements. (A) Plasma FITC-dextran concentrations and (B) Haptoglobin concentration in blood plasma. Boxplots with whisker
denoting the full ranges are shown. CON, control (grey); AMX, amoxicillin (blue); CTX, cefotaxime (green); VAN, vancomycin (yellow); MTZ, Metronidazole
(red). Significant differences from CON group are indicated by asterisks (*P < 0.05).
doi:10.1371/journal.pone.0144854.g005
Fig 6. Short chain fatty acid and succinate.Concentrations of acetate, propionate, butyrate, valerate and succinate in caecum for each treatment group.
Boxplots with whisker denoting the full range are shown. Control (grey), amoxicillin (blue), cefotaxime (green), vancomycin (yellow) and metronidazole (red).
The dashed lines indicate limit of detection. Significant differences from CON group are indicated by asterisks (*P < 0.05, **P < 0.01).
doi:10.1371/journal.pone.0144854.g006
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notable pathogenic member species (e.g. C. botulinum and C. perfringens) and the finding
could thus signify that also other potentially pathogenic bacteria may propagate due to elevated
succinate levels caused by the antibiotic induced microbial imbalance. We further found a sig-
nificant positive correlation between the relative abundance of the Clostridiaceae 1 family and
the plasma acute phase protein haptoglobin level (Fig 7B). This observation is consistent with a
previous study in cattle showing a positive correlation between faecal C. perfringens levels and
the acute-phase protein C-reactive protein (CRP) in blood plasma, although haptoglobin levels
were not affected [31]. It should be noted that an increase in haptoglobin was observed only in
animals with>0.4% Clostridiaceae 1 family (75th percentile), and that within this fraction four
out of eight animals had haptoglobin levels that were four fold higher than the average of the
CON group. Interestingly, another recent study reported a decrease in haptoglobin expression
levels following antibiotic treatment (mixture of ampicillin, gentamycin and metronidazole) of
pre-term pigs, which was suggested to be due to decreased density of the gut microbiota [32].
Our study showed that both VAN and CTX caused a decrease in intestinal permeability of
the 4 kDa FITC-dextran molecule, thus indicating a strengthening of integrity (Fig 5A). Perme-
ability of this relatively large molecule is proposed to be via the ‘leak’ pathway in the tight junc-
tion protein complex [17]. Alterations in the ‘pore’ pathway, where smaller molecules and ions
can pass, are therefore not detectable in the FITC-dextran assay. As expected, VAN, known to
target Gram positive bacteria, reduced the relative abundance of several bacterial families within
the Firmicutes and Actinobacteria phyla and increased the relative abundance of several Gram
negative bacterial families within the Proteobacteria as well as Verrucomicrobiaceae consistent
with previous studies [33]. However, a reduction of the Gram negative Porphyromonadaceae
and notably also an increase in relative abundance of the Gram positive Lactobacillaceae were
observed (Fig 3). The latter of these is consistent with the observed decrease in intestinal perme-
ability as Lactobacillus spp. have previously been shown to increase intestinal integrity in in
vitromodels [34–36]. The relative abundance of Proteobacteria was also generally increased by
VAN, which could lead to increased levels of lipopolysaccharide (LPS) to cross the intestinal
barrier and cause inflammation [13], however no increase in haptoglobin levels was seen in
VAN group (Fig 5B). Finally, bacterial families within the Firmicutes were reduced by VAN
Fig 7. Correlation analysis. (A) Spearman correlation between succinate and the relative abundance ofClostridiaceae 1 family and (B) between the relative
abundance ofClostridiaceae 1 family and plasma haptoglobin levels. Each dot represents individual animals within the CON, control (grey); AMX, amoxicillin
(blue); CTX, cefotaxime (green); VAN, vancomycin (yellow); MTZ, Metronidazole (red) groups and lines show the linear regression. Spearman r and P values
are shown.
doi:10.1371/journal.pone.0144854.g007
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including Ruminococcaceae and Lachnospiraceae, which belong to the butyrate producing Clos-
tridium clusters IV and XIVa [37]. This reduction could explain the increase in pH in the cae-
cum. Previously butyrate has been shown to decrease intestinal permeability in in vitro and
animal disease models [38,39]. The reduction of butyrate producing bacteria did, however not
increase the intestinal permeability in VAN treated animals in the present study.
For animals dosed with CTX we observed fewer significant changes in relative abundance
of bacterial families than for VAN, however an increase in Bifidobacterium spp. was found as
has previously been reported for rifaximin [40]. This is consistent with the observed positive
effect on permeability, as Bifidobacterium spp. have also been shown to increase integrity in
both in vitro and in vivomodels [41–45] however in the current study CTX additionally
increased the level of haptoglobin in the blood plasma indicating an increased level of inflam-
mation (Fig 5B).
The antibiotic MTZ caused an increase in the intestinal permeability of FITC-dextran, but
no change in the microbiota composition was detected. This indicates that MTZ may cause
alterations to the intestinal permeability independent of the gut microbiota. Others have
shown that MTZ can affect intestinal integrity in mice, indicated by a decrease in the mucus
thickness, down regulation ofMuc2, TFF3, and Relmβ gene expression and changes in the
colonic microbiota [12].
The intestinal permeability assessed by the FITC-dextran assay was not affected by AMX,
however increased levels of plasma haptoglobin were found in this group. This is interesting
since AMX resulted in major changes in the bacterial composition and diversity, including
reduction of butyrate producing bacteria (Ruminococcaceae and Lachnospiraceae) as well as
increase of Enterobacteriaceae (Figs 2 and 3). Additionally, enlargement of the caecum was
observed in the AMX and VAN groups (Fig 1D), which is consistent with previous observa-
tions in both germ-free mice [46] and antibiotic treated animals [47].
In conclusion, antibiotic induced changes in microbiota could be linked to intestinal perme-
ability, although changes in permeability did not always result from major changes in micro-
biota and vice versa. The observed varying effects of different classes of antibiotics on intestinal
integrity warrant further investigation and could potentially be important during selection of
appropriate treatment for bacterial infections.
Supporting Information
S1 Fig. Principal component analysis (PCA) of the relative abundances of detected bacterial
families in caecal and faecal samples. (A) The score plot shows samples grouped according to
treatment groups CON (black), AMX (blue), CTX (green), VAN (yellow) and MTZ (red), with
six animals in each group.  Caecal samples and + Faeces samples. (B) Loading plot indicating
each of the bacterial families colored according to phylum. Firm, Firmicutes (blue); Bact, Bac-
teroidetes (red); Prot, Proteobacteria (green), Acti, Actinobacteria (yellow); Tene, Tenericutes
(orange); Defe, deferribacteres (pink) and Verr, Verrucomicrobia (lilac).
(EPS)
S2 Fig. Principal component analysis (PCA) of the relative abundances of detected bacterial
families in ileum samples. (A) The score plot shows samples grouped according to treatment
groups CON (black), AMX (blue), CTX (green), VAN (yellow) and MTZ (red), with six ani-
mals in each group. (B) Loading plot indicating each of the bacterial families colored according
to phylum. Firm, Firmicutes (blue); Bact, Bacteroidetes (red); Prot, Proteobacteria (green),
Acti, Actinobacteria (yellow); Tene, Tenericutes (orange); Defe, deferribacteres (pink); Verr,
Verrucomicrobia (lilac) and Cyan, Cyanobacteria (cyan).
(EPS)
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S3 Fig. Gene expression of intestinal permeability markers.Mean relative gene expression of
(A) claudin-1, (B) occludin, (C) ZO-1 and (D)Muc2 in tissue samples obtained from the colon
of animals in CON,control (grey); AMX, amoxicillin (blue); CTX, cefotaxime (green); VAN,
vancomycin (yellow) and MTZ, Metronidazole (red) groups. Error bars show SEM. No signifi-
cant differences between antibiotic groups and the control group were found.
(EPS)
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